Repligen (RGEN) market cap

Market cap today
$11.04B

Repligen (RGEN) has a market cap of $11.04B. At the end of fiscal 2025 (December 31, 2025) its market cap was $9.27B. That is 15.1% higher than the $8.05B of fiscal 2024. Today's figure is 19.1% above the fiscal 2025 year-end. Figures as of 19 Nov 2026, 08:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$11.04B
Market cap, fiscal 2025
$9.27B
Change on fiscal 2024
+15.1%
Growth, 5 years
−2.2% a year
Growth, 10 years
+25.6% a year
Highest on record
$15.17Bfiscal 2021
Lowest on record
$115.12Mfiscal 2011
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Repligen market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 2.2% a year; over ten years the rate was 25.6% a year. Across the 16 fiscal year-ends on record (2010–2025), the highest was $15.17B in fiscal 2021 and the lowest $115.12M in fiscal 2011.

History · 16 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Repligen market cap, year by year

Repligen (RGEN) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$11.04B—$172.67—
2025$9.27B 15.1% up$163.8656.56M
2024$8.05B 20.6% down$143.9455.94M
2023$10.14B 4.2% up$179.8056.38M
2022$9.73B 35.9% down$169.3157.46M
2021$15.17B 46.6% up$264.8457.27M
2020$10.35B 127.3% up$191.6353.99M
2019$4.55B 89.8% up$92.5049.21M
2018$2.40B 68.8% up$52.7445.47M
2017$1.42B 34.1% up$36.2839.15M
2016$1.06B 11.5% up$30.8234.36M
2015$949.90M 44.2% up$28.2933.58M
2014$658.62M 49.0% up$19.8033.26M
2013$442.03M 125.2% up$13.6432.41M
2012$196.27M 70.5% up$6.2831.25M
2011——$3.47—
2011$115.12M 7.8% down$3.7430.78M
2010$124.85M—$4.0630.75M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Repligen and comparable companies
CompanyMarket cap
Kymera Therapeutics KYMR$10.34B
DaVita DVA$10.18B
Halozyme Therapeutics HALO$10.92B
Universal Health Services UHS$10.73B
Repligen RGEN$11.04B
Bio-Techne TECH$11.43B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on RGEN

Repligen, figure by figure

Repligen (RGEN) overview: price, valuation and scorecardAll health care companies by market value

Repligen market cap: questions and answers

What is Repligen's market cap?

Repligen (RGEN) has a market cap of $11.04B. At the end of fiscal 2025 (December 31, 2025) its market cap was $9.27B. That is 15.1% higher than the $8.05B of fiscal 2024.

What is the growth rate of Repligen's market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 2.2% a year; over ten years the rate was 25.6% a year.

What are the highest and lowest market cap figures on record for Repligen?

Across the 16 fiscal year-ends on record (2010–2025), the highest was $15.17B in fiscal 2021 and the lowest $115.12M in fiscal 2011.

How is Repligen's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Repligen it is on record here for 16 fiscal years, 2010 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Repligen (RGEN) market cap”, data as of 19 November 2026. https://funkfolio.com/stock/RGEN/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.